Related references
Note: Only part of the references are listed.Regulatory T cells in acute and chronic human Chikungunya infection
Bruna Macedo Gois et al.
MICROBES AND INFECTION (2022)
Epidemiological burden of Chikungunya fever in Brazil, 2016 and 2017
Emily Raquel Nunes Vidal et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2022)
Current Understanding of the Role of T Cells in Chikungunya, Dengue and Zika Infections
Maheshi Mapalagamage et al.
VIRUSES-BASEL (2022)
A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections
Christin Schmidt et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial
Sean R. Bennett et al.
LANCET INFECTIOUS DISEASES (2022)
Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera
Pierre Roques et al.
JCI INSIGHT (2022)
An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses
Ningning Ge et al.
VIROLOGICA SINICA (2022)
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial
Sean R. Bennett et al.
LANCET INFECTIOUS DISEASES (2022)
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
Allison August et al.
NATURE MEDICINE (2021)
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine
Roland Tschismarov et al.
JCI INSIGHT (2021)
Dengue vaccine: an update
Chung-Hao Huang et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial
Pedro M. Folegatti et al.
NATURE COMMUNICATIONS (2021)
Single-cell analysis of arthritogenic alphavirus-infected human synovial fibroblasts links low abundance of viral RNA to induction of innate immunity and arthralgia-associated gene expression
Fabian Pott et al.
EMERGING MICROBES & INFECTIONS (2021)
Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine
Lisa Henss et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes A Randomized Clinical Trial
Grace L. Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models
Wilson Nguyen et al.
VACCINES (2020)
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial
Nina Wressnigg et al.
LANCET INFECTIOUS DISEASES (2020)
Safety and immunogenicity of a mRNA-based chikungunya vaccine in a phase 1 dose-ranging trial
C. Shaw et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Molecular Basis of Arthritogenic Alphavirus Receptor MXRA8 Binding to Chikungunya Virus Envelope Protein
Hao Song et al.
CELL (2019)
Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor
Katherine Basore et al.
CELL (2019)
Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates
Shannan L. Rossi et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine
Ya-Nan Zhang et al.
JOURNAL OF VIROLOGY (2019)
A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease
Rafael Kroon Campos et al.
PATHOGENS (2019)
Defining a correlate of protection for chikungunya virus vaccines
Gregg N. Milligan et al.
VACCINE (2019)
Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge
Jesse H. Erasmus et al.
JOURNAL OF VIROLOGY (2018)
Mxra8 is a receptor for multiple arthritogenic alphaviruses
Rong Zhang et al.
NATURE (2018)
Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models
Rose M. Langsjoen et al.
MBIO (2018)
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial
Emil C. Reisinger et al.
LANCET (2018)
A chikungunya fever vaccine utilizing an insect-specific virus platform
Jesse H. Erasmus et al.
NATURE MEDICINE (2017)
Regulatory T cells and IL-10 as modulators of chikungunya disease outcome: a preliminary study
S. P. Kulkarni et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Global expansion of chikungunya virus: mapping the 64-year history
Braira Wahid et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen
Felicity J. Burt et al.
LANCET INFECTIOUS DISEASES (2017)
Chikungunya virus: clinical aspects and treatment - A Review
Rivaldo V. da Cunha et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2017)
Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus
Sixun Yang et al.
VACCINE (2017)
Vaccine platform recombinant measles virus
Michael D. Muehlebach
VIRUS GENES (2017)
CHIKUNGUNYA: A Mortality Report
Atul Gogia et al.
Open Forum Infectious Diseases (2017)
The neutralizing role of IgM during early Chikungunya virus infection
Chong-Long Chua et al.
PLOS ONE (2017)
Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus
Pierre Roques et al.
JCI INSIGHT (2017)
Global distribution and environmental suitability for chikungunya virus, 1952 to 2015
E. O. Nsoesie et al.
EUROSURVEILLANCE (2016)
A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes
Leslie Goo et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Animal Models of Chikungunya Virus Infection and Disease
Nicole N. Haese et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis
Alfonso J. Rodriguez-Morales et al.
ARTHRITIS CARE & RESEARCH (2016)
Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera
Chong-Long Chua et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress
Julie M. Fox et al.
CELL (2015)
Control of immunopathology during chikungunya virus infection
Caroline Petitdemange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
Katrin Ramsauer et al.
LANCET INFECTIOUS DISEASES (2015)
Sero-Prevalence and Cross-Reactivity of Chikungunya Virus Specific Anti-E2EP3 Antibodies in Arbovirus-Infected Patients
Yiu-Wing Kam et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
High Rate of Subclinical Chikungunya Virus Infection and Association of Neutralizing Antibody with Protection in a Prospective Cohort in The Philippines
In-Kyu Yoon et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
A Small Antigenic Determinant of the Chikungunya Virus E2 Protein Is Sufficient to Induce Neutralizing Antibodies which Are Partially Protective in Mice
Christopher Weber et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)
Rebecca Broeckel et al.
PATHOGENS (2015)
Chikungunya Vaccine Candidate Is Highly Attenuated and Protects Nonhuman Primates Against Telemetrically Monitored Disease Following a Single Dose
Chad J. Roy et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Prime-Boost Immunization Strategies against Chikungunya Virus
David Hallengard et al.
JOURNAL OF VIROLOGY (2014)
A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2014)
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
Lee-Jah Chang et al.
LANCET (2014)
Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge
Petra van den Doel et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice
James Weger-Lucarelli et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy
Simon-Djamel Thiberville et al.
ANTIVIRAL RESEARCH (2013)
A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice
Teck-Hui Teo et al.
JOURNAL OF IMMUNOLOGY (2013)
An Essential Role of Antibodies in the Control of Chikungunya Virus Infection
Fok-Moon Lum et al.
JOURNAL OF IMMUNOLOGY (2013)
A Chimeric Vesiculo/Alphavirus Is an Effective Alphavirus Vaccine
Anasuya Chattopadhyay et al.
JOURNAL OF VIROLOGY (2013)
Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response
David W. Hawman et al.
JOURNAL OF VIROLOGY (2013)
Identical Strength of the T Cell Responses against E2, nsP1 and Capsid CHIKV Proteins in Recovered and Chronic Patients after the Epidemics of 2005-2006 in La Reunion Island
Jean-Jacques Hoarau et al.
PLOS ONE (2013)
Viremic profiles in asymptomatic and symptomatic chikungunya fever: a blood transfusion threat?
Hatsadee Appassakij et al.
TRANSFUSION (2013)
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
Haiyan Chu et al.
VACCINE (2013)
Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization
Siyang Sun et al.
ELIFE (2013)
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein
Yiu-Wing Kam et al.
EMBO MOLECULAR MEDICINE (2012)
Chikungunya Virus Infection of Cell Lines: Analysis of the East, Central and South African Lineage
Nitwara Wikan et al.
PLOS ONE (2012)
Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus
Manish Kumar et al.
VACCINE (2012)
Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine
Charalambos D. Partidos et al.
VACCINE (2012)
Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice
Mohsin Khan et al.
VIRUS RESEARCH (2012)
A Mouse Model of Chikungunya Virus-Induced Musculoskeletal Inflammatory Disease Evidence of Arthritis, Tenosynovitis, Myositis, and Persistence
Thomas E. Morrison et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The Acute Phase of Chikungunya Virus Infection in Humans Is Associated With Strong Innate Immunity and T CD8 Cell Activation
Nadia Wauquier et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor
Angela Chow et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates
Karthik Mallilankaraman et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism
Kenneth Plante et al.
PLOS PATHOGENS (2011)
Active Infection of Human Blood Monocytes by Chikungunya Virus Triggers an Innate Immune Response
Zhisheng Her et al.
JOURNAL OF IMMUNOLOGY (2010)
Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and Various Evolutionary Rates
Sara M. Volk et al.
JOURNAL OF VIROLOGY (2010)
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
James E. Voss et al.
NATURE (2010)
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
Wataru Akahata et al.
NATURE MEDICINE (2010)
Chikungunya infection in children
Meghna R. Sebastian et al.
INDIAN JOURNAL OF PEDIATRICS (2009)
Prophylaxis and Therapy for Chikungunya Virus Infection
Therese Couderc et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Focus on Chikungunya pathophysiology in human and animal models
Therese Couderc et al.
MICROBES AND INFECTION (2009)
Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus
Mugdha Tiwari et al.
VACCINE (2009)
Serious acute chikungunya virus infection requiring intensive care during the reunion island outbreak in 2005-2006
Jerome Lemant et al.
CRITICAL CARE MEDICINE (2008)
Resurgence of chikungunya
Harold Townson et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Discovery of frameshifting in Alphavirus 6K resolves a 20-year enigma
Andrew E. Firth et al.
VIROLOGY JOURNAL (2008)
Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India
Dileep Mavalankar et al.
EMERGING INFECTIOUS DISEASES (2008)
A single mutation in chikungunya virus affects vector specificity and epidemic potential
Konstantin A. Tsetsarkin et al.
PLOS PATHOGENS (2007)
Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus
Ann M. Powers et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218
R Edelman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2000)
Share Paper
